The National Pharmaceuticals Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has fixed the trade margin limit on the maximum retail price (MRP) of 137 anti-cancer drugs based on the recommendations of the expert committee constituted by the Directorate General of Health Services (DGHS), Ministry of Health and Family Welfare on October 17, 2026. The revised MRP of these medicines has come into effect from today, November 9, 2026.
As of November 8, 2026, 85 pharmaceutical companies have informed the revised MRP for 1,364 anti-cancer formulations covering 121 drugs. In which 679 brands have reported price reduction of more than 50%. The maximum reduction in MRP has been recorded at 96.45%. As a result of this reduction in prices, customers are expected to save an estimated amount of ₹ 3,540.38 crore annually.
Customers can see the revised MRP printed on the medicine package and check the medicine prices through 'Pharma Sahi Daam' mobile application or NPPA website (nppa.gov.in). No chemist or hospital pharmacy will be able to charge more than the revised MRP. If you are overcharged or have any other price related complaint, you can lodge your complaint on the Pharma Jan Samadhan Portal or contact the NPPA helpline at 1800-111-255.